ALR Technologies Announces Partnership With Mid-America Coalition on Health Care (MACHC)

RICHMOND, VA--(Marketwire - Mar 13, 2013) -  ALR Technologies (OTCBB: ALRT) and the Mid-America Coalition on Health Care today announced a partnership in which the MACHC will introduce and offer pilot participation of ALRT's Health-e-Connect Diabetes Management Program to their membership. The Mid-American Coalition is the second oldest business related health care coalition in the U.S. and consists of 67 member organizations representing more than 500,000 employees in the Greater Kansas City area. The goal of the partnership is to assist their multi-stakeholder membership, some of which are the largest employers in the Kansas City area, better manage and reduce the costs for their employees living with diabetes. 

The Health-e-Connect Program is a remote monitoring and care facilitation program that allows ALRT Diabetes Care Facilitators to monitor patient blood glucose data and, based on clinician approved protocols, provide advice, support and interventions when patients show readings that are out of an acceptable range or if they are failing to test their blood glucose as prescribed. The ALRT Health-e-Connect System has been successfully proven in a clinical trial that demonstrated this type of remote care is associated with significant lowering of A1c levels. The study concluded that continuing intervention using an internet based glucose monitoring system is an effective way of improving glucose control compared to conventional care.

MACHC President and CEO Troy Ross said: "Throughout our 33 year history, our mission is focused on identifying and offering solutions that improve the way health care is designed and delivered so that our members can better manage their healthcare costs. The Health-e-Connect Program is an innovative tool that aligns with our mission to provide solutions that improve quality and lower the costs of expensive chronic diseases such as diabetes." Mr. Ross added, "MACHC is proud to be sought out as a leading force in helping Kansas City employers create and sustain a healthy community, now and in the future. We have a rich history of collaborating on innovative offerings in care and benefit design that have become best practices in the employer community both locally and across the nation. Diabetes is projected to be the fastest growing disease state over the next decade. Finding new methods to manage and lower the costs associated with diabetes is an important objective for our employers and we're looking forward to working with ALRT to deliver a solution that offers incremental and sustainable change."

ALR Technologies CEO Sidney Chan commented: "We are proud to be associated with the Mid-America Coalition on Health Care. They represent a significant cross section of some of America's finest companies and we look forward to assisting them in managing the cost of one of the great drivers in health insurance today: diabetes care." 

Under the terms of the partnership, ALRT agreed to devote a portion of any revenue derived from the project to MACHC.

About the Mid-America Coalition on Health Care

The Mid-America Coalition on Health Care leverages the expertise, experience, and resources of its multi-disciplinary membership to promote the health and well being of current and future employees and their families in the greater Kansas City area.

Through the power of collaboration and utilizing innovative best practices, MACHC provides leadership and acts as a catalyst to effect positive changes for containing health care costs and improving health outcomes.

About ALR Technologies Inc.

ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange.